Product Information
HEMORRHOIDAL OINTMENT is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.0571 per GM under NDC 45802018816. Its NADAC has been published 633 times since Aug 20, 2014.
Strength
14; 74.9; .25 g/100g; g/100g; g/100g
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802018816
Classification
Generic
Dosage Form
OINTMENT
Route
RECTAL
Effective Date
9/23/2026
Active Ingredients
MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M015On Market Since
11/1/2013
Pharmacological Classes
Price Statistics
The NADAC for HEMORRHOIDAL OINTMENT has been published 633 times since Aug 20, 2014, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0571 per GM |
|---|---|
| All-time high | $0.0617 (Jul 15, 2020) |
| All-time low | $0.0389 (Sep 22, 2021) |
| 52-week high | $0.0571 |
| 52-week low | $0.0508 |
| Median price | $0.0485 |
| Average price | $0.0483 |
| Largest weekly change | +34.9% (Aug 23, 2023) |
| Weeks tracked | 633 |
| Tracking since | Aug 20, 2014 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Padagis Israel Pharmaceuticals Ltd manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
mineral oil, petrolatum, phenylephrine HCl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-1 Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HEMORRHOIDAL OINTMENT?
The current National Average Drug Acquisition Cost (NADAC) for HEMORRHOIDAL OINTMENT, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.0571 per GM (NDC 45802018816), effective Sep 30, 2026.
How has the price of HEMORRHOIDAL OINTMENT changed over time?
Over the history we have for it, the NADAC for HEMORRHOIDAL OINTMENT has held within roughly two percent of its current level. It has been tracked across 633 weekly CMS publications since Aug 20, 2014.
What are the highest and lowest recorded NADAC prices for HEMORRHOIDAL OINTMENT?
Since Aug 20, 2014, the NADAC for HEMORRHOIDAL OINTMENT has ranged from a low of $0.0389 (Sep 22, 2021) to a high of $0.0617 (Jul 15, 2020), with a median of $0.0485 per GM.
Are there cheaper alternatives to HEMORRHOIDAL OINTMENT?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as HEMORRHOIDAL OINTMENT in a comparable dosage form, but none are currently priced below it.
Who manufactures HEMORRHOIDAL OINTMENT?
HEMORRHOIDAL OINTMENT (NDC 45802018816) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.